Quibim, a global leader in quantitative medical imaging solutions, today announced that its flagship solution, QP-Prostate, ...

For only the second time in almost a quarter of a century, Cancer Research UK is seeking a new headline partner for its Race ...

An international team led by researchers at The Hospital for Sick Children (SickKids), Princess Margaret Cancer Centre, ...

A study out of Sweden finds that people diagnosed with localized prostate cancer are unlikely to die from the cancer if they ...

Anal cancer is a rare yet increasing cancer linked primarily to high-risk HPV strains such as HPV-16 and HPV-18. Key risk factors include weakened immune systems, age over 50, and high-risk sexual ...

A study out of Sweden finds that people diagnosed with localized prostate cancer are unlikely to die from the cancer if they ...

The update strengthens IBTROZI's position as a next-generation treatment in a rare, aggressive lung cancer that often spreads ...

At Cancer Research UK, we know that innovation is essential to developing our understanding of cancer and how we transform cancer prevention, diagnosis and treatment. We have experience supporting ...

Scientists have developed a new technique described as a ‘powerful double weapon’ to help patients keep their hair. It ...

The cancer cachexia market is expected to witness an expansion across the 7MM, driven by the introduction of innovative therapies, ponsegromab (PF-06946860), S-pindolol benzoate (ACM-001.1) ...

Cancer Research UK has awarded £457,000 to support a pioneering study in Cambridge that could play a pivotal role in the ...

What is cancer? Cancer starts when cells change abnormally Cancer is when abnormal cells divide in an uncontrolled way. Some cancers may eventually spread into other tissues. There are more than 200 ...